TELEFLEX INCORPORATED COMMON STOCK

Teleflex Announces Full U.S. Commercial Launch of the UroLift® 2 System and UroLift ATC ® Advanced Tissue Control System

13 May 2022 05:30:00 By Nasdaq GlobeNewswire

Teleflex to Host Analyst & Investor Day on May 20, 2022

02 May 2022 05:45:00 By Nasdaq GlobeNewswire

Teleflex Announces Quarterly Dividend

02 May 2022 05:30:00 By Nasdaq GlobeNewswire

Teleflex Reports First Quarter Financial Results And Full Year Outlook

28 Apr 2022 05:30:00 By Nasdaq GlobeNewswire

Teleflex Named to Forbes Best Employers for Diversity 2022 List

26 Apr 2022 05:45:00 By Nasdaq GlobeNewswire

Teleflex to Present at the Bank of America Securities 2022 Healthcare Conference

26 Apr 2022 05:30:00 By Nasdaq GlobeNewswire

Teleflex Announces First Quarter 2022 Earnings Conference Call Information

14 Apr 2022 05:30:00 By Nasdaq GlobeNewswire

Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia (BPH)

11 Apr 2022 05:30:00 By Nasdaq GlobeNewswire

Teleflex to Present at the KeyBanc Life Sciences & MedTech Investor Forum

09 Mar 2022 05:30:00 By Nasdaq GlobeNewswire

Teleflex to Present at the 43rd Annual Raymond James Institutional Investors Conference

02 Mar 2022 05:30:00 By Nasdaq GlobeNewswire

Teleflex Announces Quarterly Dividend

24 Feb 2022 05:45:00 By Nasdaq GlobeNewswire

Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results

24 Feb 2022 05:30:01 By Nasdaq GlobeNewswire

Teleflex Receives FDA Clearance for Expanded Indication for Specialty Catheter and Coronary Guidewire Use in CTO PCI Procedures

23 Feb 2022 05:30:00 By Nasdaq GlobeNewswire

Teleflex Announces Fourth Quarter and Full Year 2021 Earnings Conference Call Information

10 Feb 2022 05:30:00 By Nasdaq GlobeNewswire

Teleflex to Present at the 40th Annual J.P. Morgan Healthcare Conference

04 Jan 2022 05:30:00 By Nasdaq GlobeNewswire

Teleflex Receives Reimbursement Approval for the UroLift® System in Japan

13 Dec 2021 05:30:00 By Nasdaq GlobeNewswire

Teleflex Incorporated Announces Worldwide Recall of Arrow-Trerotola™ Over-The-Wire PTD® Kit Percutaneous Thrombolytic Device: 7FR

26 Nov 2021 17:00:00 By Nasdaq GlobeNewswire

Teleflex Earns Top Spot in MedReps Best Places to Work 2022 Ranking

18 Nov 2021 05:45:00 By Nasdaq GlobeNewswire

Teleflex to Participate in the 33rd Annual Virtual Piper Sandler Healthcare Conference

18 Nov 2021 05:30:00 By Nasdaq GlobeNewswire

Teleflex Integrates Medical Education and Training with Explorer Surgical to Expand Urologists’ Access to Procedural Expertise

04 Nov 2021 05:30:00 By Nasdaq GlobeNewswire